Outcomes of patients with blastomycosis-associated respiratory failure requiring veno-venous ECMO: a case series
Therapeutic Advances in Respiratory Disease · 2024
DOI: 10.1177/17534666241277616 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Advances in Respiratory Disease, 2024. Verfasst von Roman Melamed und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care, Abbott Northwestern Hospital, Allina Health, Minneapolis, MN 55407-3799, USA. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Respiratory Insufficiency, Blastomycosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Blastomycosis can result in lung injury with high mortality rates. The literature on veno-venous extracorporeal membrane oxygenation (VV-ECMO) used as a rescue therapy is limited to case reports and small case series collected over extended time periods. This report describes the clinical course and post-hospitalization outcomes among patients with blastomycosis-induced respiratory failure requiring VV-ECMO in the most recent time frame. The data were collected retrospectively from the health records of eight patients with blastomycosis-induced respiratory failure admitted to a tertiary care center between 2019 and 2023. The mean time from the start of mechanical ventilation to ECMO initiation was 57 h. All patients survived to ECMO decannulation, and seven of them survived to hospital discharge. All six patients whose post-discharge follow-up information was available were weaned from mechanical ventilation and lived at home while two required supplemental oxygen. This includes a case where the provision of adequate ECMO support was challenging due to the patient’s morbid obesity. The most common residual imaging abnormalities included pulmonary infiltrates and pneumatoceles. The study demonstrates the feasibility of VV-ECMO as a rescue therapy in patients with blastomycosis-related refractory respiratory failure. Rapid initiation of ECMO support in eligible patients may have contributed to the good outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Critical Care, Abbott Northwestern Hospital, Allina Health, Minneapolis, MN 55407-3799, USA.
- Department of Graduate Medical Education, Abbott Northwestern Hospital, Allina Health, Minneapolis, MN, USA.
- Department of Medicine, Abbott Northwestern Hospital, Allina Health, Minneapolis, MN, USA.
- Allina Health Research, Minneapolis, MN, USA.
- Department of Critical Care, Abbott Northwestern Hospital, Allina Health, Minneapolis, MN, USA.
ORCID-Profile: Roman Melamed
Zitieren
APA
Melamed, R., Tierney, D. M., Martins, S., Zamorano, C., Hahn, M., & Saavedra, R. (2024). Outcomes of patients with blastomycosis-associated respiratory failure requiring veno-venous ECMO: a case series. Therapeutic Advances in Respiratory Disease. https://doi.org/10.1177/17534666241277616
Vancouver
Melamed R, Tierney DM, Martins S, Zamorano C, Hahn M, Saavedra R. Outcomes of patients with blastomycosis-associated respiratory failure requiring veno-venous ECMO: a case series. Therapeutic Advances in Respiratory Disease. 2024. doi:10.1177/17534666241277616
BibTeX
@article{Melamed2024,
author = {Melamed, Roman and Tierney, David M and Martins, Summer and Zamorano, Clara and Hahn, Madison and Saavedra, Ramiro},
title = {Outcomes of patients with blastomycosis-associated respiratory failure requiring veno-venous ECMO: a case series},
journal = {Therapeutic Advances in Respiratory Disease},
year = {2024},
doi = {10.1177/17534666241277616}
}
EUVIMED